These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21285534)

  • 1. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
    Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
    Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
    Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
    Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A outbreaks: the effect of a mass vaccination programme.
    Torner N; Broner S; Martinez A; Godoy P; Batalla J; Dominguez A;
    J Viral Hepat; 2011 Apr; 18(4):e1-4. PubMed ID: 21129127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of hepatitis A before and after the introduction of a universal vaccination programme in Catalonia, Spain.
    Domínguez A; Oviedo M; Carmona G; Jansá JM; Borrás E; Salleras L; Plasència A
    J Viral Hepat; 2008 Oct; 15 Suppl 2():51-6. PubMed ID: 18837835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme.
    Godoy P; Carmona G; Manzanares S; Jane M; Borràs E; Camps N; Álvarez J; Barrabeig I; Sala MR; Rius C; Minguell S; Carol M; Ferras J; Domínguez A;
    J Viral Hepat; 2018 Sep; 25(9):1001-1007. PubMed ID: 29603832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction.
    Domínguez A; Oviedo M; Carmona G; Batalla J; Bruguera M; Salleras L; Plasència A
    Vaccine; 2008 Mar; 26(14):1737-41. PubMed ID: 18325642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
    Borràs E; Urbiztondo L; Carmona G; Jané M; Barrabeig I; Rosa Sala M; Jorgina Balañà JP; Company M; Parrón I; Godoy P; Rius C; Soldevila N; Cabezas C; Domínguez À;
    Vaccine; 2019 Feb; 37(9):1137-1141. PubMed ID: 30709729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a mass hepatitis A vaccination program in preadolescents.
    Domínguez A; Salleras L; Carmona G; Batalla J
    Vaccine; 2003 Jan; 21(7-8):698-701. PubMed ID: 12531343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.
    Parrón I; Planas C; Godoy P; Manzanares-Laya S; Martínez A; Sala MR; Minguell S; Torner N; Jané M; Domínguez A;
    Hum Vaccin Immunother; 2017 Feb; 13(2):423-427. PubMed ID: 27925847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of universal hepatitis A immunization of children in Minsk City, Belarus: four-year follow-up.
    Fisenka EG; Germanovich FA; Glinskaya IN; Lyabis OI; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():57-61. PubMed ID: 18837836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
    Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
    Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010.
    Crespo I; Broner S; Soldevila N; Martínez A; Godoy P; Sala-Farré MR; Company M; Rius C; Domínguez A; Group Of Catalonia TP
    Hum Vaccin Immunother; 2015; 11(1):231-5. PubMed ID: 25483541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
    Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
    Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hepatitis A in the United States in the era of vaccination.
    Wasley A; Samandari T; Bell BP
    JAMA; 2005 Jul; 294(2):194-201. PubMed ID: 16014593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
    Estripeaut D; Contreras R; Tinajeros O; Castrejón MM; Shafi F; Ortega-Barria E; DeAntonio R
    Vaccine; 2015 Jun; 33(28):3200-7. PubMed ID: 25981490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Hepatitis A Twelve Years After the Implementation of Toddlers' Vaccination: A Population-Based Study in Israel.
    Bassal R; Weil M; Cohen D; Sofer D; Mendelson E; Shohat T
    Pediatr Infect Dis J; 2017 Oct; 36(10):e248-e251. PubMed ID: 28498301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hepatitis A in Israel following universal immunization of toddlers.
    Dagan R; Leventhal A; Anis E; Slater P; Ashur Y; Shouval D
    JAMA; 2005 Jul; 294(2):202-10. PubMed ID: 16014594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of a population outbreak of hepatitis A. Effectiveness of vaccination as a control measure].
    Díaz Villaescusa MJ; Almar Marqués E; Gómez Martínez A; Mateos Ramos A; Segura Cebollada P; de la Cruz de Julián I; Navarro Honrubia C; Ramírez Córcoles C
    Gac Sanit; 2010; 24(4):329-33. PubMed ID: 20483510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.
    Suijkerbuijk AW; Lugnér AK; van Pelt W; Wallinga J; Verhoef LP; de Melker HE; de Wit GA
    Vaccine; 2012 Jul; 30(35):5199-205. PubMed ID: 22721900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.